Skip to content
‹ Back to IndustriesSciences

Hyundai Motors Acquires Boston Dynamics: How Can Robotics Scale Car Manufacturing?

Hyundai Motors has acquired Boston Dynamics for over $1 billion, signaling a significant move towards increased use of robotics in car manufacturing. The investment is seen as a step towards integrating advanced automation and enhancing research and development for new vehicles. Experts believe combining robotics with human efforts could lead to improved manufacturing efficiency.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Daniel Litwin · · AutomationAutomotiveAutomotive ManufacturingBoston Dynamics
Share
Hyundai Motors Acquires Boston Dynamics: How Can Robotics Scale Car Manufacturing?

Key takeaways

01

Hyundai Motors invested more than $1 billion in acquiring Boston Dynamics to advance robotics in automotive manufacturing.

02

Experts believe the integration of robotics is aimed at enhancing research and development efforts rather than immediate large-scale changes.

03

A symbiotic relationship between humans and robotic systems could lead to significant efficiency gains in manufacturing.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Automotive industry giant Hyundai Motors made waves recently, acquiring noted robotics lab Boston Dynamics for more than $1 billion. That’s a hefty investment – but what does it really represent?

To find out, Voice of B2B Daniel Litwin sat down with Konstantin Maslennikov, CEO and Founder of HereYouGo, which is working to empower anyone to rent part of a fleet of autonomous vehicles as we collectively move toward a self-driving future.

Even though Hyundai’s aggressive move represents a big step toward increased automation, Maslennikov said the process might be more glacier than avalanche.

“You cannot change everything in one day,” he said. “I think it’s more for research and development purposes, mostly. … Maybe for new vehicles.”

The duo explored where Hyundai might get the most out of its investment in Boston Dynamics, how robotic solutions are getting smarter and preparing to scale up, the role of automation in self-driving vehicle manufacturing at scale, and more.

While many companies are working toward that future, it’s still easier to use humans than artificial intelligence in some applications.

“It’s going to be some kind of symbiosis,” Maslennikov said. “Because, if people work with computers, the efficiency just grows very fast. … But we are not there yet, especially with AI enablement. Like, robots making robots? Robots making self-driving cars? We are not there yet.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

Daniel Litwin
Daniel LitwinEditor, B2B Media, MarketScale

Daniel Litwin is a journalist of multiple disciplines focused on finding and telling engaging stories for B2B communities. He has interviewed executives from Fortune 500 companies including Honeywell, Microsoft, John Deere, and Chipotle, and leads editorial direction at MarketScale. Litwin hosts weekly shows and podcasts while helping develop new content approaches across the MarketScale platform. He holds a B.J. in Radio/Television Reporting/Anchoring and a B.A. in Spanish from the University of Missouri-Columbia.

B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030

IndexBox sees replacements driving a third of quantum cascade laser shipments by 2030

IndexBox projects the quantum cascade laser market to grow 8% to 12% a year through 2035, linking the outlook to faster adoption of mid-infrared spectroscopy in process control, environmental monitoring and pharmaceutical QA. It says QCLs win on high spectral brightness and room-temperature operation in compact form factors, and that the installed base of analytical instruments is growing.

  • 01Roughly one in three quantum cascade lasers shipped in 2030 is projected to replace equipment already in service, so maintenance calendars will set a growing share of demand.
  • 02For a plant or QA lab running QCL-based analyzers, the useful question is which laser maker sits inside each instrument and whether a second source exists.
  • 03Analyzers bought on a three-to-five-year cycle in 2026 come due between 2029 and 2031. Those years will show whether the forecast replacement wave turns up in real orders.

Oct 26, 2026

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu cites digitalization, personalization and large-volume delivery as trends reshaping drug delivery devices, arguing structured data can enable reuse and cut duplicated design-file work for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of IV and SC agents.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

Daniel Litwin
Daniel Litwin

Voice of B2B at MarketScale

MarketScale

Daniel Litwin is a communications specialist focused on B2B industries, providing insights and commentary across a range of sectors. He works with MarketScale to deliver valuable insights in engineering, construction, and technology fields.

KM
Konstantin Maslennikov

CEO and Founder

HereYouGo

Konstantin Maslennikov is the CEO and Founder of HereYouGo, a company focused on advancing autonomous vehicle technology and enabling rental models for fleet sharing. He is a thought leader in self-driving technology and automation.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512